Literature DB >> 27484309

Indications to Epigenetic Dysfunction in the Pathogenesis of Common Variable Immunodeficiency.

William Rae1.   

Abstract

Primary immunodeficiencies (PIDs) are a group of rare genetic diseases resulting in the impairment of one or more functions of the human immune system. Common variable immunodeficiency (CVID) is one of the most prevalent PIDs, yet despite extensive genetic analysis, most patients do not have a monogenetic diagnosis. This has led to the theory that CVID must be a polygenetic condition. An alternative theory to a monogenetic or polygenetic underlying cause of CVID is that it is epigenetic phenomena that are causal in the majority of CVID patients. I will briefly discuss epigenetic regulation in B-cell biology and development, current examples of epigenetic diseases causing CVID-like primary antibody deficiencies, and how these observations may guide future investigation into the role of epigenetics in CVID.

Entities:  

Keywords:  B-cell development; Common variable immunodeficiency; Epigenetics

Mesh:

Substances:

Year:  2016        PMID: 27484309     DOI: 10.1007/s00005-016-0414-x

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  11 in total

1.  Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency.

Authors:  Arianna Troilo; Claudia Wehr; Iga Janowska; Nils Venhoff; Jens Thiel; Justyna Rawluk; Natalie Frede; Julian Staniek; Raquel Lorenzetti; Marei-Theresa Schleyer; Georg W Herget; Lukas Konstantinidis; Miriam Erlacher; Michele Proietti; Nadezhda Camacho-Ordonez; Reinhard Edmund Voll; Bodo Grimbacher; Klaus Warnatz; Ulrich Salzer; Marta Rizzi
Journal:  Blood       Date:  2020-04-23       Impact factor: 22.113

Review 2.  Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.

Authors:  Silje F Jørgensen; Børre Fevang; Pål Aukrust
Journal:  J Clin Immunol       Date:  2018-11-21       Impact factor: 8.317

3.  Diagnostic Yield and Therapeutic Consequences of Targeted Next-Generation Sequencing in Sporadic Primary Immunodeficiency.

Authors:  Georgios Sogkas; Natalia Dubrowinskaja; Katharina Schütz; Lars Steinbrück; Jasper Götting; Nicolaus Schwerk; Ulrich Baumann; Bodo Grimbacher; Torsten Witte; Reinhold E Schmidt; Faranaz Atschekzei
Journal:  Int Arch Allergy Immunol       Date:  2021-10-07       Impact factor: 2.749

4.  Comprehensive phenotyping of human peripheral blood B lymphocytes in pathological conditions.

Authors:  Rita Carsetti; Francesco Corrente; Claudia Capponi; Mattia Mirabella; Simona Cascioli; Patrizia Palomba; Valentina Bertaina; Daria Pagliara; Manuela Colucci; Eva Piano Mortari
Journal:  Cytometry A       Date:  2021-12-01       Impact factor: 4.714

5.  Differently expressed microRNA in response to the first Ig replacement therapy in common variable immunodeficiency patients.

Authors:  Bruna De Felice; Ersilia Nigro; Rita Polito; Francesca Wanda Rossi; Antonio Pecoraro; Giuseppe Spadaro; Aurora Daniele
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

6.  Variable immunodeficiency score upfront analytical link (VISUAL), a proposal for combined prognostic score at diagnosis of common variable immunodeficiency.

Authors:  Kissy Guevara-Hoyer; Adolfo Jiménez-Huete; Julia Vasconcelos; Esmeralda Neves; Silvia Sánchez-Ramón
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

7.  Common variable immunodeficiency: different faces of the same disease.

Authors:  Elżbieta Grześk; Anna Dąbrowska; Anna Urbañczyk; Marlena Ewertowska; Mariusz Wysocki; Sylwia Kołtan
Journal:  Postepy Dermatol Alergol       Date:  2021-11-05       Impact factor: 1.837

Review 8.  Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.

Authors:  R C P Luna; Y de Oliveira; J V C Lisboa; T R Chaves; T A M de Araújo; E E de Sousa; M Miranda Neto; L Pirola; V A Braga; J L de Brito Alves
Journal:  Braz J Med Biol Res       Date:  2018-10-18       Impact factor: 2.590

Review 9.  Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID.

Authors:  Giuliana Amato; Federica Vita; Paolina Quattrocchi; Paola Lucia Minciullo; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

10.  Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience.

Authors:  Maria Giovanna Danieli; Cristina Mezzanotte; Jacopo Umberto Verga; Denise Menghini; Veronica Pedini; Maria Beatrice Bilò; Gianluca Moroncini
Journal:  Biomedicines       Date:  2022-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.